- Filed
- Feb 24, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Feb 17, 2025 | 31.3M sh |
| Shares Diluted restated | FY 2024 · Dec 31, 2023 | 28.13M sh |
| Capex | FY 2024 · Dec 31, 2023 | $5.56M |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | $5.9M |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $13.81M |
| Stockholders Equity | FY 2024 · Dec 31, 2023 | $25.7M |
| Stockholders Equity | FY 2024 · Dec 31, 2022 | $18.77M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $22.94M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $34.44M |
| Current Assets | FY 2024 · Dec 31, 2023 | $32.08M |
| Total Assets | FY 2024 · Dec 31, 2023 | $59.43M |
| Eps Diluted | FY 2024 · Dec 31, 2023 | −$0.03 |
| Eps Basic | FY 2024 · Dec 31, 2023 | −$0.03 |
| Sga Expense | FY 2024 · Dec 31, 2023 | $30.98M |
| Net Income | FY 2024 · Dec 31, 2023 | −$908K |
| Operating Income | FY 2024 · Dec 31, 2023 | $318K |
| Gross Profit | FY 2024 · Dec 31, 2023 | $31.29M |
| Revenue | FY 2024 · Dec 31, 2023 | $86.78M |